<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Liu Y</submitter><funding>Putuo district clinical Chinese medicine fund</funding><funding>The Clinical Special Project fund of Shanghai Municipal Health Commission</funding><pagination>185</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8207779</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>19(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Circulating tumor cells (CTCs) are the dominant factor leading to tumor metastasis. This study aims to investigate the effect of disparate sources of CTCs on the treatment and prognosis of patients with advanced tumors by analyzing the number and gene mutations change of CTCs in arterial and venous blood in patients with advanced tumors.&lt;h4>Results&lt;/h4>A CTCs sorting system was constructed based on Vimentin-immunolipid magnetic balls (Vi-IMB) and EpCAM immunolipid magnetic balls (Ep-IMB). Results showed that the prepared Ep-IMB and Vi-IMB had lower cytotoxicity, better specificity and sensitivity. The number of arterial CTCs was higher than that of venous CTCs, with a statistically significant difference (P &lt; 0.05). Moreover, the prognosis of the low positive group of to</pubmed_abstract><journal>Journal of nanobiotechnology</journal><pubmed_title>Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor.</pubmed_title><pmcid>PMC8207779</pmcid><funding_grant_id>PTZYLCZDZK-2017001/ptzyzk2101</funding_grant_id><funding_grant_id>20204Y0153</funding_grant_id><pubmed_authors>Liu Y</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Song P</pubmed_authors><pubmed_authors>Liu L</pubmed_authors><pubmed_authors>Liang X</pubmed_authors><pubmed_authors>Zhang X</pubmed_authors><pubmed_authors>Shen T</pubmed_authors><pubmed_authors>Li Q</pubmed_authors><pubmed_authors>Jiang T</pubmed_authors><pubmed_authors>Chen T</pubmed_authors></additional><is_claimable>false</is_claimable><name>Clinical verification of vimentin/EpCAM immunolipid magnetic sorting system in monitoring CTCs in arterial and venous blood of advanced tumor.</name><description>&lt;h4>Background&lt;/h4>Circulating tumor cells (CTCs) are the dominant factor leading to tumor metastasis. This study aims to investigate the effect of disparate sources of CTCs on the treatment and prognosis of patients with advanced tumors by analyzing the number and gene mutations change of CTCs in arterial and venous blood in patients with advanced tumors.&lt;h4>Results&lt;/h4>A CTCs sorting system was constructed based on Vimentin-immunolipid magnetic balls (Vi-IMB) and EpCAM immunolipid magnetic balls (Ep-IMB). Results showed that the prepared Ep-IMB and Vi-IMB had lower cytotoxicity, better specificity and sensitivity. The number of arterial CTCs was higher than that of venous CTCs, with a statistically significant difference (P &lt; 0.05). Moreover, the prognosis of the low positive group of to</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Jun</publication><modification>2025-04-19T14:00:10.436Z</modification><creation>2022-02-10T16:00:38.755Z</creation></dates><accession>S-EPMC8207779</accession><cross_references><pubmed>34134721</pubmed><doi>10.1186/s12951-021-00929-x</doi></cross_references></HashMap>